Appl Clin Inform 2018; 09(04): 849-855
DOI: 10.1055/s-0038-1676039
DOI: 10.1055/s-0038-1676039
Research Article
Evaluation of Clinical Relevance of Drug–Drug Interaction Alerts Prior to Implementation
Autoren
-
S. M. M. Meslin
1 Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia2 St Vincent's Clinical School, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia3 School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia -
W. Y. Zheng
4 Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia -
R. O. Day
1 Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia2 St Vincent's Clinical School, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia -
E. M. Y. Tay
1 Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia -
M. T. Baysari
2 St Vincent's Clinical School, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia4 Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia

